Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor
about
Atypical IκB proteins - nuclear modulators of NF-κB signalingImpaired B cell development and function in the absence of IkappaBNSThemis controls thymocyte selection through regulation of T cell antigen receptor-mediated signalingRegulation of the Adaptive Immune Response by the IκB Family Protein Bcl-3NF-κB, the first quarter-century: remarkable progress and outstanding questionsNF-κB regulation: lessons from structuresCentral tolerance: learning self-control in the thymusNF-kappaB and the regulation of hematopoiesisIkappaBeta, a nuclear IkappaB protein, positively regulates the NF-kappaB-mediated expression of proinflammatory cytokinesEvolutionary, structural and functional interplay of the IκB family members.Alternative nuclear functions for NF-κB family membersThe nuclear IκB family protein IκBNS influences the susceptibility to experimental autoimmune encephalomyelitis in a murine modelHistone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytesA forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunityNF-kappaB guides the survival and differentiation of developing lymphocytes.NF-kappa B as a therapeutic target in autoimmune disease.Molecular basis of NF-κB signalingThe roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.Plxnd1 expression in thymocytes regulates their intrathymic migration while that in thymic endothelium impacts medullary topology.A structural guide to proteins of the NF-kappaB signaling module.IκBζ: an emerging player in cancer.The complicated role of NF-kappaB in T-cell selection.It takes two to tango: IκBs, the multifunctional partners of NF-κB.NF-κB signaling in B-1 cell development.Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity.Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer TreatmentThe Nuclear Protein IκBζ Forms a Transcriptionally Active Complex with Nuclear Factor-κB (NF-κB) p50 and the Lcn2 Promoter via the N- and C-terminal Ankyrin Repeat Motifs.Gene-specific requirement of a nuclear protein, IkappaB-zeta, for promoter association of inflammatory transcription regulators.Targeting IκBNS in allergic asthma: where it resides, matters.IκBNS induces Muc5ac expression in epithelial cells and causes airway hyper-responsiveness in murine asthma models.Targeting IκappaB kinases for cancer therapy.
P2860
08df8a3b981178a9196a34abc4de97e125b25bf510daa541a952f8e38282b29143f4be1c78a944f01f369d14447c61184c2db8822164e70f201787573ca810ab3aa47940afccc9b1009f6053f2975cd14120780b133b649b85f6638675a4243475e99d5a435c3173d5c5bd65f77713d79a7aef3e5237e5a947e0979dba436760a5dacfa9ef448a55a18f18fa4a863775f366a2eaef2dbd4d2749d71242571492631d571770111d65df75625d47b548820ee1db1e9d7d1021f1de8cae275a051ff1f51d08d108b266b44e84985e1a371c0ddd15a8723017b6f57dcb03ff867d19603911f2f0ec09c09ef954c0de15f960
P248
Q21245512-C2C1EBF2-FEC7-4380-A185-7F52AA5A3AA5Q24625466-51E3B7AB-15E0-46E1-BDC4-74A0BCA916AEQ24657605-3C5C63C3-FF13-422A-9AE9-EDD2208A2674Q26749588-D8196566-4E09-451B-9EF2-1DBE16225379Q26822516-47544C85-472A-442D-977D-26303A478113Q26859097-4C191808-A5FE-4384-8223-2134D25FD0A4Q28275215-4B680E13-0A43-430D-9815-D55DEC1FFB5BQ28301261-1E8F4196-83EB-4F0B-B715-B4FA52F827DBQ28509093-C4EC81FE-759C-4667-9089-7BDC013323FFQ34571003-4FDED06B-DCF1-4186-B8E5-9C2700D8BF66Q35263997-FEEAB11A-60D7-4CD0-9EC5-8E1C029EA89EQ35367737-AEE69574-0363-4313-9EA8-E2A1FC82EFD6Q35949614-050686FC-F479-4CE2-826D-B23AEB4ED8AFQ36140212-F9DBA032-C343-40E7-87C7-7AB23761A646Q36417751-21BF5442-2C86-4A8C-9C39-F55BD524B093Q36709522-C5DB063A-C72B-4FD7-B4EA-B1BB96115B88Q36918115-97CFA74D-F0E4-4077-A5B6-734661CA1E01Q36955377-1EDB71B2-8CC8-4046-A928-107F3C468060Q37321840-976D8BF6-8A53-47AC-85D9-267A410A3B1BQ37412660-BC827B7A-556A-4C04-A2FC-2E9D2C23770DQ37662411-7C00519C-57A8-4A69-AA5C-FE5D8FF970A6Q37700164-EBE44037-C977-4A76-B7BA-F3F72F9B6599Q37995679-BC3EBFF5-BD02-46E4-B0F7-69AE925C8E64Q38533864-994C4613-C02D-4DDC-AFD3-398377946FB6Q38644746-95BD3903-D6E7-4B77-AF50-992A65DD1326Q40648639-65AE749D-8C71-43A2-9C16-35EAFA8FB51DQ41161836-01965070-F06B-437A-A332-3A06797D7F6EQ42807929-4321B011-F46D-447D-A563-9E7E5E40110FQ46256350-F267051A-A849-4C33-9AC8-8078B9A4E4DCQ51308611-0A582C59-59CD-4E18-A5AF-D904E13340F4Q52372117-D6C7DE9E-4AE0-4188-B373-E27718C49C40
P2860
Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@ast
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@en
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@en-gb
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@nl
type
label
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@ast
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@en
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@en-gb
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@nl
prefLabel
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@ast
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@en
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@en-gb
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@nl
P2093
P921
P3181
P1433
P1476
Peptide-induced negative selec ...... ion of an NF-kappa B inhibitor
@en
P2093
Ada M Kruisbeek
Elena V Tibaldi
Ellis L Reinherz
Emma Fiorini
Linda K Clayton
Maki Touma
Rebecca E Hussey
Stephanie L Osborn
Tetsuro Sasada
Wilfred E Marissen
P304
P3181
P356
10.1016/S1097-2765(02)00469-0
P407
P577
2002-03-01T00:00:00Z